Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1950 5
1951 3
1952 2
1953 5
1954 1
1955 6
1956 4
1957 1
1958 2
1959 2
1960 2
1961 2
1962 1
1963 10
1964 4
1965 4
1966 8
1967 9
1968 10
1969 6
1970 7
1971 11
1972 7
1973 11
1974 7
1975 12
1976 9
1977 18
1978 14
1979 7
1980 9
1981 7
1982 6
1983 11
1984 16
1985 13
1986 18
1987 13
1988 21
1989 20
1990 15
1991 17
1992 16
1993 34
1994 35
1995 22
1996 25
1997 20
1998 27
1999 17
2000 23
2001 16
2002 26
2003 15
2004 27
2005 21
2006 14
2007 31
2008 30
2009 21
2010 34
2011 33
2012 28
2013 27
2014 28
2015 35
2016 24
2017 34
2018 39
2019 40
2020 51
2021 55
2022 5
Text availability
Article attribute
Article type
Publication date

Search Results

1,149 results
Results by year
Filters applied: . Clear all
Page 1
Neuromyelitis optica spectrum disorders.
Huda S, Whittam D, Bhojak M, Chamberlain J, Noonan C, Jacob A. Huda S, et al. Among authors: chamberlain j. Clin Med (Lond). 2019 Mar;19(2):169-176. doi: 10.7861/clinmedicine.19-2-169. Clin Med (Lond). 2019. PMID: 30872305 Free PMC article. Review.
Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.
Kapur J, Elm J, Chamberlain JM, Barsan W, Cloyd J, Lowenstein D, Shinnar S, Conwit R, Meinzer C, Cock H, Fountain N, Connor JT, Silbergleit R; NETT and PECARN Investigators. Kapur J, et al. Among authors: chamberlain jm. N Engl J Med. 2019 Nov 28;381(22):2103-2113. doi: 10.1056/NEJMoa1905795. N Engl J Med. 2019. PMID: 31774955 Free PMC article. Clinical Trial.
Progress toward Gene Therapy for Duchenne Muscular Dystrophy.
Chamberlain JR, Chamberlain JS. Chamberlain JR, et al. Among authors: chamberlain js. Mol Ther. 2017 May 3;25(5):1125-1131. doi: 10.1016/j.ymthe.2017.02.019. Epub 2017 Apr 15. Mol Ther. 2017. PMID: 28416280 Free PMC article. Review.
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial.
Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, Rogers A, Barsan W, Cloyd J, Lowenstein D, Bleck TP, Conwit R, Meinzer C, Cock H, Fountain NB, Underwood E, Connor JT, Silbergleit R; Neurological Emergencies Treatment Trials; Pediatric Emergency Care Applied Research Network investigators. Chamberlain JM, et al. Lancet. 2020 Apr 11;395(10231):1217-1224. doi: 10.1016/S0140-6736(20)30611-5. Epub 2020 Mar 20. Lancet. 2020. PMID: 32203691 Free PMC article. Clinical Trial.
AAV-based gene therapies for the muscular dystrophies.
Crudele JM, Chamberlain JS. Crudele JM, et al. Among authors: chamberlain js. Hum Mol Genet. 2019 Oct 1;28(R1):R102-R107. doi: 10.1093/hmg/ddz128. Hum Mol Genet. 2019. PMID: 31238336 Free PMC article. Review.
Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT).
Bernhardt J, Churilov L, Ellery F, Collier J, Chamberlain J, Langhorne P, Lindley RI, Moodie M, Dewey H, Thrift AG, Donnan G; AVERT Collaboration Group. Bernhardt J, et al. Among authors: chamberlain j. Neurology. 2016 Jun 7;86(23):2138-45. doi: 10.1212/WNL.0000000000002459. Epub 2016 Feb 17. Neurology. 2016. PMID: 26888985 Free PMC article. Clinical Trial.
Viral vector-mediated gene therapies.
Hollinger K, Chamberlain JS. Hollinger K, et al. Among authors: chamberlain js. Curr Opin Neurol. 2015 Oct;28(5):522-7. doi: 10.1097/WCO.0000000000000241. Curr Opin Neurol. 2015. PMID: 26263476 Free PMC article. Review.
1,149 results